W BRADFORD MIDDLEKAUFF
CIK 1214501 · CBO, GC and Secretary · last filed 2025-10-28
W BRADFORD MIDDLEKAUFF is a CBO, GC and Secretary who has filed 16 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for TRML, was dated Oct 28, 2025. Across all open-market trades the lifetime net is −$99.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.67M
5
16
-$99.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Tourmaline Bio, Inc. (TRML) Delisted | CBO, GC and Secretary | 8,213 | $47.98 | $394.1K | $0 | 2 | 2025-10-28 |
| Immunovant, Inc. (IMVTW) Delisted | General Counsel | — | — | — | $0 | 2 | 2020-05-18 |
| PDSB | Senior VP, GC and Secretary | 73,770 | $1.05 | $77.5K | $0 | 1 | 2019-03-18 |
| EDGE | Senior VP, GC and Secretary | 22,707 | $49.07 | $1.11M | $94.8K | 8 | 2018-12-31 |
| MEDX | SVP, General Counsel & Sec. | 13,878 | $34.49 | $478.6K | -$194.6K | 2 | 2007-09-05 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-28 | Tourmaline Bio, Inc. (TRML) Delisted | Mixed | −69,201 | $0 | EDGAR |
| 2025-01-29 | Tourmaline Bio, Inc. (TRML) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-10-23 | — | Grant (A) | +69,201 | $0 | |
| 2020-05-18 | Immunovant, Inc. (IMVTW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-20 | Immunovant, Inc. (IMVTW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-18 | PDSB | Exer (M) | +49,766 | $0 | EDGAR |
| 2018-12-31 | EDGE | — | — | $0 | EDGAR |
| 2018-08-15 | EDGE | Grant (A) | — | $0 | EDGAR |
| 2018-06-20 | EDGE | Grant (A) | — | $0 | EDGAR |
| 2018-03-05 | EDGE | Grant (A) | — | $0 | EDGAR |